Ironwood Pharmaceuticals (IRWD) Financials: Revenue & Earnings
$589.08M
Market Cap
4.35
P/E
2.91
Forward P/E
—
Score
IRWD price $3.56 +0.06 +1.57%
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 273957000 | 298276000 | 346639000 | 428413000 | 389523000 | 413753000 | 410596000 | 442735000 | 351410000 | 296151000 |
Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions. Its flagship commercial product is linaclotide, a guanylate cyclase type-C (GC-C) agonist. This medication is prescribed for adult patients managing irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic…
IRWD fair value $36.04. Price $3.56. Price is 90% below fair value.
Below fair value, and cheaper than usual. A larger discount than on 85% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 185.55M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 165.24M. Net debt 382.35M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-09 | — | 0.32 | — | 119.99M |
| 2026-08-06 | 0.31 | 0.32 | 113.04M | 114.84M |
| 2026-05-07 | 0.24 | 0.07 | 106.51M | 92.11M |
| 2026-02-25 | -0.01 | 0.02 | 47.71M | 50.92M |
| 2025-11-10 | 0.24 | 0.09 | 122.06M | 74.71M |
| 2025-08-07 | 0.14 | -0.02 | 85.24M | 60.77M |
| 2025-05-07 | -0.23 | -0.05 | 41.14M | 45.90M |
| 2025-02-27 | 0.02 | 0.12 | 90.55M | 93.77M |
| 2024-11-07 | 0.02 | 0.08 | 91.59M | 91.22M |
| 2024-08-08 | -0.01 | 0.15 | 94.40M | 107.10M |
| 2024-05-09 | -0.02 | 0.19 | 74.88M | 105.75M |
| 2024-02-15 | -0.01 | 0.21 | 117.55M | 117.47M |
| 2023-11-09 | 0.09 | 0.16 | 113.74M | 114.00M |
| 2023-08-08 | 0.31 | 0.25 | 107.38M | 103.70M |
| 2023-05-04 | 0.25 | 0.24 | 104.06M | 100.35M |
| 2023-02-16 | 0.27 | 0.27 | 107.20M | 108.04M |
| 2022-11-03 | 0.28 | 0.27 | 108.64M | 109.15M |
| 2022-08-04 | 0.21 | 0.30 | 97.23M | 103.55M |
| 2022-05-05 | 0.21 | 0.26 | 97.53M | 96.62M |
| 2022-02-17 | 0.27 | 0.31 | 117.13M | 110.17M |
| 2021-11-04 | 0.33 | 0.31 | 103.75M | 106.42M |
| 2021-08-05 | 0.34 | 0.23 | 104.03M | 104.03M |
| 2021-05-06 | 0.24 | 0.21 | 88.84M | 90.17M |
| 2021-02-17 | 0.36 | 0.29 | 116.68M | 111.95M |
| 2020-11-05 | 0.23 | 0.15 | 103.47M | 67.48M |
| 2020-08-06 | 0.16 | 0.09 | 89.43M | 73.78M |
| 2020-05-06 | 0.04 | 0.05 | 79.94M | 99.93M |
| 2020-02-13 | 0.30 | 0.24 | 126.30M | 101.04M |
| 2019-10-31 | 0.40 | 0.11 | 131.17M | 36.07M |
| 2019-07-30 | 0.10 | -0.03 | 102.22M | 30.66M |
| 2019-05-02 | -0.26 | -0.14 | 68.73M | 54.68M |
| 2019-02-13 | -0.02 | -0.15 | 130.69M | 980.19M |
| 2018-11-06 | -0.38 | -0.17 | 65.69M | 57.38M |
| 2018-08-06 | -0.28 | -0.21 | 81.11M | 60.83M |
| 2018-05-01 | -0.27 | -0.23 | 69.16M | 58.95M |
| 2018-02-15 | -0.14 | -0.18 | 94.21M | 121.11M |
| 2017-11-02 | -0.18 | -0.22 | 86.83M | 106.09M |
| 2017-08-03 | -0.30 | -0.22 | 65.08M | 51.15M |
| 2017-05-08 | -0.36 | -0.20 | 52.17M | 45.19M |
| 2017-02-21 | -0.09 | -0.24 | 87.46M | 233.33M |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-15 | DENNER ALEXANDER J | Buy | 3.69K | — | — |
| 2026-07-20 | Silber Jeffrey | Buy | 137.04K | — | — |
| 2026-07-20 | Silber Jeffrey | Other | 0 | — | — |
| 2026-07-07 | Silver Ronald | Sell | 127.89K | $4.52 | 578.06K |
| 2026-06-16 | Shepard Jay | Buy | 63.48K | — | — |
| 2026-06-16 | Kessler Marla L | Buy | 63.48K | — | — |
| 2026-06-16 | Currie Mark G | Buy | 63.48K | — | — |
| 2026-06-16 | Duane Jon R | Buy | 63.48K | — | — |
| 2026-06-16 | DENNER ALEXANDER J | Buy | 63.48K | — | — |
| 2026-06-16 | McHugh Julie | Buy | 63.48K | — | — |
| 2026-06-16 | McHugh Julie | Sell | 21.57K | $3.73 | 80.46K |
| 2026-06-16 | Moukheibir Catherine | Buy | 63.48K | — | — |
| 2026-06-15 | DENNER ALEXANDER J | Buy | 4.07K | — | — |
| 2026-05-19 | Silver Ronald | Buy | 25.00K | — | — |
| 2026-03-17 | DENNER ALEXANDER J | Sell | 6.72M | $3.05 | 20.51M |
| 2026-03-17 | DENNER ALEXANDER J | Sell | 5.80K | $3.31 | 19.20K |
| 2026-03-13 | DENNER ALEXANDER J | Buy | 4.45K | — | — |
| 2026-03-10 | John Minardo | Buy | 136.61K | — | — |
| 2026-03-10 | Martini Gregory S. | Buy | 136.61K | — | — |
| 2026-03-10 | Gaskins Tammi L | Buy | 136.61K | — | — |
| 2026-03-10 | Shetzline Michael | Buy | 136.61K | — | — |
| 2026-03-10 | Silver Ronald | Buy | 163.93K | — | — |
| 2026-03-10 | MCCOURT Thomas A | Buy | 409.84K | — | — |
| 2026-02-24 | John Minardo | Sell | 19.05K | $3.66 | 69.73K |
| 2026-02-24 | Shetzline Michael | Buy | 17.01K | $3.66 | 62.26K |
| 2026-02-24 | Gaskins Tammi L | Sell | 11.24K | $3.66 | 41.13K |
| 2026-02-24 | MCCOURT Thomas A | Sell | 103.53K | $3.66 | 378.91K |
| 2026-02-24 | Martini Gregory S. | Sell | 11.46K | $3.66 | 41.93K |
| 2026-02-24 | Silver Ronald | Sell | 12.62K | $3.66 | 46.19K |
| 2026-02-23 | John Minardo | Sell | 17.44K | $3.81 | 66.44K |
| 2026-02-23 | Shetzline Michael | Sell | 15.57K | $3.81 | 59.32K |
| 2026-02-23 | Gaskins Tammi L | Sell | 10.29K | $3.81 | 39.19K |
| 2026-02-23 | MCCOURT Thomas A | Sell | 94.76K | $3.81 | 361.02K |
| 2026-02-23 | Martini Gregory S. | Sell | 10.49K | $3.81 | 39.96K |
| 2026-02-23 | Silver Ronald | Sell | 11.55K | $3.81 | 44.01K |
| 2026-01-05 | Silver Ronald | Sell | 35.42K | $4.60 | 162.91K |
| 2025-12-15 | DENNER ALEXANDER J | Buy | 4.18K | — | — |
| 2025-11-17 | Gaskins Tammi L | Sell | 6.02K | $3.32 | 19.97K |
| 2025-09-15 | DENNER ALEXANDER J | Buy | 11.72K | — | — |
| 2025-08-11 | Gaskins Tammi L | Sell | 1.32K | $0.84 | 1.11K |
| 2025-08-11 | John Minardo | Sell | 7.75K | $0.84 | 6.51K |
| 2025-08-11 | Martini Gregory S. | Sell | 1.26K | $0.84 | 1.06K |
| 2025-08-11 | Silver Ronald | Sell | 2.85K | $0.84 | 2.39K |
| 2025-06-13 | DENNER ALEXANDER J | Buy | 24.19K | — | — |
| 2025-06-10 | Kessler Marla L | Buy | 45.00K | — | — |
| 2025-06-10 | Shepard Jay | Buy | 45.00K | — | — |
| 2025-06-10 | Moukheibir Catherine | Buy | 45.00K | — | — |
| 2025-06-10 | Duane Jon R | Buy | 45.00K | — | — |
| 2025-06-10 | Currie Mark G | Buy | 45.00K | — | — |
| 2025-06-10 | McHugh Julie | Buy | 45.00K | — | — |
| 2025-06-10 | Dreyfus Andrew | Buy | 45.00K | — | — |
| 2025-06-10 | DENNER ALEXANDER J | Buy | 45.00K | — | — |
| 2025-05-20 | MCCOURT Thomas A | Buy | 540.00K | — | — |
| 2025-05-16 | MCCOURT Thomas A | Sell | 13.35K | $0.58 | 7.74K |
| 2025-05-16 | Gaskins Tammi L | Sell | 2.56K | $0.58 | 1.49K |
| 2025-04-02 | DENNER ALEXANDER J | Buy | 10.42K | — | — |
| 2025-03-11 | Gaskins Tammi L | Other | 0 | — | — |
| 2025-02-10 | MCCOURT Thomas A | Sell | 139.06K | $1.76 | 244.75K |
| 2025-02-10 | Silver Ronald | Sell | 12.05K | $1.76 | 21.20K |
| 2025-02-10 | Shetzline Michael | Buy | 133.33K | — | — |
| 2025-02-10 | Shetzline Michael | Sell | 41.27K | $1.76 | 72.63K |
| 2025-02-10 | John Minardo | Buy | 122.22K | — | — |
| 2025-02-10 | John Minardo | Sell | 38.94K | $1.76 | 68.53K |
| 2025-02-10 | Martini Gregory S. | Sell | 12.05K | $1.76 | 21.21K |
| 2025-01-27 | Silver Ronald | Buy | 133.33K | — | — |
| 2025-01-27 | Martini Gregory S. | Buy | 111.11K | — | — |
| 2025-01-27 | Martini Gregory S. | Other | 0 | — | — |
| 2025-01-27 | Martini Gregory S. | Other | 3.31K | $16.90 | 55.89K |
| 2025-01-27 | Martini Gregory S. | Other | 1.59K | $12.95 | 20.55K |
| 2025-01-17 | Shetzline Michael | Buy | 48.22K | — | — |
| 2025-01-17 | John Minardo | Buy | 40.19K | — | — |
| 2025-01-17 | MCCOURT Thomas A | Buy | 147.35K | — | — |
| 2024-12-16 | DENNER ALEXANDER J | Buy | 4.25K | — | — |
| 2024-11-18 | Davis Andrew | Sell | 5.36K | $4.08 | 21.87K |
| 2024-11-18 | Emany Sravan Kumar | Sell | 11.00K | $4.08 | 44.88K |
| 2024-09-16 | DENNER ALEXANDER J | Buy | 3.28K | — | — |
| 2024-08-12 | John Minardo | Sell | 9.91K | $4.27 | 42.32K |
| 2024-08-12 | Silver Ronald | Sell | 3.11K | $4.27 | 13.27K |
| 2024-06-18 | Shepard Jay | Buy | 24.31K | — | — |
| 2024-06-18 | Dreyfus Andrew | Buy | 24.31K | — | — |
| 2024-06-18 | Duane Jon R | Buy | 24.31K | — | — |
| 2024-06-18 | McHugh Julie | Buy | 24.31K | — | — |
| 2024-06-18 | Moukheibir Catherine | Buy | 24.31K | — | — |
| 2024-06-18 | Kessler Marla L | Buy | 24.31K | — | — |
| 2024-06-18 | DENNER ALEXANDER J | Buy | 24.31K | — | — |
| 2024-06-18 | Currie Mark G | Buy | 24.31K | — | — |
| 2024-06-15 | DENNER ALEXANDER J | Buy | 2.57K | — | — |
| 2024-06-10 | McHugh Julie | Sell | 22.77K | $6.29 | 143.20K |
| 2024-06-07 | Moukheibir Catherine | Sell | 35.57K | $6.61 | 235.14K |
| 2024-06-06 | Moukheibir Catherine | Sell | 44.43K | $6.36 | 282.55K |
| 2024-05-20 | MCCOURT Thomas A | Sell | 67.62K | $6.45 | 436.14K |
| 2024-05-20 | Davis Andrew | Sell | 22.73K | $6.45 | 146.58K |
| 2024-05-20 | Shetzline Michael | Sell | 16.13K | $6.45 | 104.03K |
| 2024-05-20 | John Minardo | Sell | 17.40K | $6.45 | 112.26K |
| 2024-05-16 | Emany Sravan Kumar | Sell | 18.28K | $6.64 | 121.38K |
| 2024-03-15 | DENNER ALEXANDER J | Buy | 1.66K | — | — |
| 2024-03-08 | John Minardo | Buy | 32.75K | — | — |
| 2024-03-08 | John Minardo | Sell | 32.75K | — | — |
| 2024-03-08 | Emany Sravan Kumar | Buy | 37.12K | — | — |
| 2024-03-08 | Emany Sravan Kumar | Sell | 37.12K | — | — |
Latest filed quarter: Q2 2026.
Institutions holding: 220, holders -15 vs prior quarter. Ownership 99.03%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 17.79M | 4.43M | +33.12% | 74.89M |
| ARMISTICE CAPITAL, LLC | 13.93M | -1.10M | -7.29% | 58.65M |
| SARISSA CAPITAL MANAGEMENT LP | 9.19M | 0 | 0.00% | 38.68M |
| STATE STREET CORP | 8.81M | 1.35M | +18.14% | 37.09M |
| BANK OF AMERICA CORP /DE/ | 8.68M | 896 | +0.01% | 36.56M |
| RENAISSANCE TECHNOLOGIES LLC | 7.99M | -67.85K | -0.84% | 33.65M |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.61M | 511.05K | +8.38% | 27.82M |
| AQR CAPITAL MANAGEMENT LLC | 6.47M | -1.07M | -14.19% | 27.22M |
| ACADIAN ASSET MANAGEMENT LLC | 5.85M | -723.94K | -11.01% | 24.62M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.51M | -1.17M | -17.49% | 23.21M |
| GEODE CAPITAL MANAGEMENT, LLC | 4.83M | 288.13K | +6.34% | 20.35M |
| TWO SIGMA INVESTMENTS, LP | 4.56M | -1.29M | -22.10% | 19.18M |
| MARSHALL WACE, LLP | 4.29M | -234.97K | -5.19% | 18.06M |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 4.07M | 433.49K | +11.93% | 17.12M |
| GOLDMAN SACHS GROUP INC | 3.31M | 623.17K | +23.16% | 13.95M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3.30M | -1.44M | -30.30% | 13.90M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 3.30M | 3.30M | New | 13.90M |
| FEDERATED HERMES, INC. | 3.23M | -117.57K | -3.51% | 13.60M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 3.02M | -380.15K | -11.19% | 12.70M |
| DIMENSIONAL FUND ADVISORS LP | 2.52M | 440.84K | +21.17% | 10.62M |
| MACKENZIE FINANCIAL CORP | 2.37M | 1.81M | +322.74% | 9.97M |
| MORGAN STANLEY | 1.86M | 1.04M | +125.49% | 7.83M |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 1.81M | -23.71K | -1.29% | 7.63M |
| NORTHERN TRUST CORP | 1.37M | 108.13K | +8.54% | 5.78M |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 1.25M | 13.80K | +1.12% | 5.26M |
Ironwood Pharmaceuticals, Inc. (IRWD) trades at $3.56, with a market cap of $589.08M and a trailing P/E of 4.35. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 273957000 | 298276000 | 346639000 | 428413000 | 389523000 | 413753000 | 410596000 | 442735000 | 351410000 | 296151000 |
Insights · Dividends · Forecast · Financials · Learn
$589.08M
Market Cap
4.35
P/E
2.91
Forward P/E
—
Score